Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma
Aim: Due to the limits of calcitonin, other markers are warranted to better manage medullary thyroid carcinoma
patients, and procalcitonin has been reported as promising. Here we aimed to evaluate procalcitonin as a marker
of medullary thyroid carcinoma in the post-treatment follow-up.
Methods: Medullary thyroid carcinoma patients previously treated by thyroidectomy were enrolled. After complete
imaging work-up (i.e. ultrasonography, computed tomography, magnetic resonance and 18FDG-PET-CT) we